Coya Therapeutics (COYA) Change in Cash (2022 - 2026)

Coya Therapeutics has reported Change in Cash for 5 years, with the latest figure at $3.9 million in Q1 2026.

• Quarterly Change in Cash rose 238.9% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.2 million (up 3411.82% YoY) and the FY2025 annual result came in at $8.5 million, up 48.49% from the prior year.
• Change in Cash retreated to $3.9 million in Q1 2026 per COYA's latest filing, from $18.7 million in the prior quarter.
• Over five years, Change in Cash peaked at $21.7 million in Q4 2023 and troughed at -$5.8 million in Q2 2025.
• A 5-year average of $2.7 million and a median of -$1.6 million in 2025 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2025: Change in Cash jumped 900.12% in 2023, then slumped 1085.74% in 2025.
• Over 5 years, Change in Cash stood at -$2.7 million in 2022, then surged by 900.12% to $21.7 million in 2023, then slumped by 66.5% to $7.3 million in 2024, then surged by 156.69% to $18.7 million in 2025, then sank by 79.13% to $3.9 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $3.9 million, $18.7 million, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.